Rationale: During embryogenesis, the CXC chemokine ligand (CXCL)12 acts on endothelial cells to control cardiac development and angiogenesis. Although biological functions of CXCL12 are exerted in part through activation of the small GTPase Rac, the pathway leading from its receptor CXC chemokine receptor (CXCR)4 to Rac activation remains to be determined.
D uring embryogenesis, progenitor cells migrate to specific locations, where they differentiate into specialized cells that make up different tissues and organs. This process is coordinately regulated by extrinsic guidance cues. The CXC chemokine ligand (CXCL)12 is one of such cues critical for cardiovascular development. Mice lacking CXCL12 or its receptor CXC chemokine receptor (CXCR)4 exhibit ventricular septal defect (VSD) and poor vascularization of the gastrointestinal tract. 1, 2 In developing heart, CXCR4 is predominantly expressed on endocardial cells in the atrioventricular (AV) canal, 3 which are destined to participate in formation of the membranous septa and valves. Similarly, the expression of CXCR4 in developing vessels is limited to arterial endothelial cells. 4 Thus, CXCL12 acts on endothelial cells to control cardiac development and angiogenesis during embryogenesis.
On binding to CXCR4, CXCL12 induces dissociation of heterodimeric G proteins into ␣ and ␤␥ subunits, which results in the activation of a variety of signaling pathways including Rac. Like other small GTPases, Rac cycles between GDP-bound inactive and GTP-bound active states, and stimulus-induced formation of the active Rac is mediated by guanine nucleotide exchange factors (GEFs). However, the mechanism controlling Rac activation downstream of CXCR4 is unknown during cardiovascular development.
DOCK180 (dedicator of cytokinesis), a mammalian ortholog of Caenorhabditis elegans CED-5 and Drosophila melanogaster Myoblast City, 5,6 controls cell migration and phagocytosis in vitro 7, 8 and myoblast fusion in vivo. 9 DOCK180 does not contain the pleckstrin homology and Dbl homology domains typically found in GEFs for Rho family GTPases. 10 However, DOCK180 can bind to phosphatidylinositol 3,4,5-triphosphate through its DHR-1 domain 11 and mediate the GTP-GDP exchange for Rac by means of its DHR-2 (also known as Docker) domain. 10, 12 In this study, we examined the functions of DOCK180 during cardiovascular development.
Methods
Biochemical, histological, and functional analyses were performed by standard methods. An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results and Discussion
DOCK180 associates with ELMO (engulfment and cell motility) through the N-terminal region containing a Src homology (SH)3 domain and a putative ␣-helical region. 7, 13 To investigate the physiological role of the SH3 domain of DOCK180, we specifically deleted a portion of this domain in mice by gene targeting (Online Figure I) . Although mating between heterozygous mice yielded homozygous mutants nearly at Mendelian ratio throughout gestation, no viable homozygous offspring was obtained (Online Table I ). Close examination of umbilical blood flow indicated that some homozygous mutants were dead at embryonic day (E)17.5 and E18.5. As in DOCK180-deficient (DOCK180 Ϫ/Ϫ ) embryos, 9 a defect in myogenesis was also observed in homozygous mutants lacking DOCK180 SH3 domain (DOCK180 d/d ) (Online Figure II ). In addition, both DOCK180 d/d and DOCK180 Ϫ/Ϫ embryos exhibited severe edema in the large area of the back at E14.5 ( Figure 1A ; Online Figure III ).
Whereas Northern blot analysis of whole embryos revealed that DOCK180 gene was normally transcribed in DOCK180 d/d mice, DOCK180 protein level was reduced to Ͻ10% of the wild-type (WT) level ( Figure 1B) .
To understand the mechanism of protein decrease in the mutant animals, we examined protein degradation using CHO cells stably expressing green fluorescent protein (GFP)tagged WT DOCK180 or its mutant bearing the same deletion as in DOCK180 d/d mice (designated SH3del). Pulse-chase experiments revealed that the SH3del mutant was more rapidly degraded than WT DOCK180 ( Figure 1C ). The proteasome inhibitor MG132 blocked this degradation, but bafilomycin had no effect, indicating that deletion of the SH3 domain leads to proteasome-dependent degradation of DOCK180 ( Figure 1C ). When the SH3del mutant was transiently expressed with ELMO1 in HEK293T cells, its binding to ELMO1 was modestly diminished ( Figure 1D ), in agreement with a nonessential role of this domain for ELMObinding. 13 However, whereas ubiquitination of WT DOCK180 was suppressed by coexpression of ELMO1 in the presence of MG132, such inhibitory effect was less profound for the SH3del mutant ( Figure 1E ), suggesting that the interaction of DOCK180 SH3 domain with ELMO is required to inhibit ubiquitination and degradation of DOCK180.
Because DOCK180 d/d mice exhibited severe edema, we hypothesized that they might have defects in cardiovascular development. Indeed, cardiac abnormalities such as submembranous VSD and double outlet right ventricle (DORV) were detected in all DOCK180 d/d embryos examined at E14.5 (Figure 2A ). Similar results were obtained when DOCK180 Ϫ/Ϫ embryos were analyzed (Online Figure  III) . In both DOCK180 d/d and DOCK180 Ϫ/Ϫ embryos, mitral valve leaflets were also thickened and in some of them fused, which accounted for the blood retention in left atrium ( Figure  2A ; Online Figure III) . Side-by-side analyses revealed that Figure  2A ). When DOCK180 SH3 domain was specifically deleted in endothelial cells using Tie2-Cre transgenic mice, these mice also exhibited VSD and DORV (Online Figure IV) , thus confirming the endothelial origin of the cardiac defects in DOCK180 d/d embryos. Cardiac endothelial cells in the AV canal undergo transforming growth factor-␤dependent epithelial-mesenchymal transformation (EMT) and migrate into an extracellular matrix referred to as the cardiac jelly. 14 This process is important to form endocardial cushion from which AV valves and membranous septa originate. At E8.5, before EMT initiates, DOCK180 d/d and WT littermates were indistinguishable concerning the heart development. However, the endocardial cushion of DOCK180 d/d embryos showed a significantly decreased cellularity at E12.5 ( Figure 2B ). In heart explant assays, cardiac endothelial cells from both WT and DOCK180 d/d embryos were widely spread on the gel, showing spindle-like mesenchymal morphology ( Figure 2C ). However, although cells from the WT explants effectively invaded the gel, the number of invading cells significantly decreased in the case of DOCK180 d/d explants ( Figure 2D ). It is clear that DOCK180 is not required for EMT itself, because endothelial cells from WT and DOCK180 d/d embryos comparably transformed into mesenchymal cells expressing ␣-smooth muscle actin (␣-SMA) ( Figure 2E ).
Non-standard Abbreviations and Acronyms
Because CXCR4 is required for vascularization of the gastrointestinal tract, 2,4 we examined whether DOCK180 also functions in vascular endothelial cells. During embryogenesis, the small intestine begins to develop as a simple tube called a midgut loop. When the midgut loop of WT embryos was analyzed at E12.5, many branches were found to arise from the ␣-SMA-positive superior mesenteric artery (Figure 3A) . However, as in CXCR4 Ϫ/Ϫ embryos, the interconnecting vessels between superior mesenteric artery and the capillary plexus were severely reduced in DOCK180 d/d midgut loop ( Figure 3A) . Similarly, at E15.5, large vessels poorly developed in the stomach of DOCK180 d/d embryos ( Figure 3A) .
To examine whether DOCK180 functions downstream of CXCR4, we purified arterial endothelial cells from WT and DOCK180 d/d embryos. In chemotaxis assays, WT endothelial cells efficiently migrated to the lower chamber in response to either CXCL12 or vascular endothelial growth factor (VEGF). However, migratory response to CXCL12, but not to VEGF, was almost completely lost for DOCK180 d/d endothelial cells ( Figure 3B ). Consistent with this finding, CXCL12-induced peripheral membrane ruffle formation was scarcely detected in DOCK180 d/d endothelial cells ( Figure  3C ). To obtain biochemical evidence that DOCK180 controls Rac activation downstream of CXCR4, we used human aorta endothelial cells. In these cells, knockdown of DOCK180 expression by RNA interference abrogated CXCL12-induced Rac activation ( Figure 3D ).
Here we have shown that DOCK180 is required for cardiovascular development. Importantly, DOCK180 knockdown does not affect the expression or localization of CXCL12 and CXCR4 in vivo (Online Figure V) . In addition, DOCK180 and CXCR4 are coexpressed in cardiac and vascular endothelial cell lineage (Online Figure VI) . Our results thus indicate that DOCK180 links CXCR4 signaling to Rac activation to control endothelial cell migration during cardiovascular development.
